These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 24681187

  • 1. (153)Sm-EDTMP for pain relief of bone metastases from prostate and breast cancer and other malignancies.
    Correa-González L, Arteaga de Murphy C, Pichardo-Romero P, Pedraza-López M, Moreno-García C, Correa-Hernández L.
    Arch Med Res; 2014 May; 45(4):301-8. PubMed ID: 24681187
    [Abstract] [Full Text] [Related]

  • 2. Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer.
    Dolezal J, Vizda J, Odrazka K.
    Urol Int; 2007 May; 78(1):50-7. PubMed ID: 17192733
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: a phase II study.
    Yuan J, Liu C, Liu X, Wang Y, Kuai D, Zhang G, Zaknun JJ.
    Clin Nucl Med; 2013 Feb; 38(2):88-92. PubMed ID: 23334120
    [Abstract] [Full Text] [Related]

  • 4. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.
    Baczyk M, Czepczyński R, Milecki P, Pisarek M, Oleksa R, Sowiński J.
    Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585
    [Abstract] [Full Text] [Related]

  • 5. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.
    Liepe K, Runge R, Kotzerke J.
    J Cancer Res Clin Oncol; 2005 Jan; 131(1):60-6. PubMed ID: 15449184
    [Abstract] [Full Text] [Related]

  • 6. Impact of ¹⁸F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP.
    Storto G, Gallicchio R, Pellegrino T, Nardelli A, De Luca S, Capacchione D, Sirignano C, Pace L.
    Nucl Med Biol; 2013 May; 40(4):518-23. PubMed ID: 23522973
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and toxicity of 153samarium-EDTMP in painful breast cancer bone metastases.
    Dolezal J.
    Onkologie; 2009 Feb; 32(1-2):35-9. PubMed ID: 19209017
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
    Liepe K, Kotzerke J.
    Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Myelotoxicity after systemic radionuclide therapy of painful bone metastases with 153Samarium-EDTMP ].
    Dolezal J, Vizd'a J, Cermáková E.
    Vnitr Lek; 2003 Mar; 49(3):189-93. PubMed ID: 12728593
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Analgesic response and secondary effects in patients with osteoblastic metastasis, treated with Samarium 153 ethylenediaminotetramethylenephosphate].
    Lovera C, Massardo T, Galleguillos MC, González P, Comparini B, Yáñez M, Fodor M, Gil MC, Araya G, Tomicic M.
    Rev Med Chil; 1998 Aug; 126(8):963-71. PubMed ID: 9830748
    [Abstract] [Full Text] [Related]

  • 16. Prospective dosimetry with 99mTc-MDP in metabolic radiotherapy of bone metastases with 153Sm-EDTMP.
    Bianchi L, Baroli A, Marzoli L, Verusio C, Chiesa C, Pozzi L.
    Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):122-9. PubMed ID: 18751975
    [Abstract] [Full Text] [Related]

  • 17. 153Sm-EDTMP for bone pain palliation in skeletal metastases.
    Maini CL, Bergomi S, Romano L, Sciuto R.
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S171-8. PubMed ID: 15127241
    [Abstract] [Full Text] [Related]

  • 18. Samarium-153-EDTMP in bone metastases.
    Ahonen A, Joensuu H, Hiltunen J, Hannelin M, Heikkilä J, Jakobsson M, Jurvelin J, Kairemo K, Kumpulainen E, Kulmala J.
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):123-7. PubMed ID: 7543288
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.